Drug & Medical Device On Trial

Wednesday, July 18, 2007

About

Jury awards against drug and device companies are staggering.

Fine tune the skills you need to succeed at trial in the event your case doesn't settle.

In 2006, medical products liability litigation produced plaintiffs' verdicts of $13.5 million, $32 million, and $51 million (source: National Law Journal, Feb. 26, 2007). It's no secret that these verdicts have a significant impact on the company's bottom line. And as plaintiff attorneys use sympathetic plaintiffs, media bias, and poor juror perception of the drug and device industries to their advantage in high-risk and costly products liability trials, there is simply no room for error in the courtroom.

The time is now for you to benchmark your advocacy strategy and tactics at the ultimate trial skills presentation for pharmaceutical and medical device manufacturers and their counsel.

From soup to nuts, top defense litigators who are in the trenches making news and setting precedents will demonstrate :

  • jury selection;
  • opening and closing statements;
  • cross-examination of the plaintiff, treating physician, and the plaintiff 's epidemiologist, pharmacologist, and regulatory/FDA expert; and
  • direct examination of company witnesses and the defense epidemiologist, pharmacologist, and regulatory/FDA expert

Contents & Contributors

About

Jury awards against drug and device companies are staggering.

Fine tune the skills you need to succeed at trial in the event your case doesn't settle.

In 2006, medical products liability litigation produced plaintiffs' verdicts of $13.5 million, $32 million, and $51 million (source: National Law Journal, Feb. 26, 2007). It's no secret that these verdicts have a significant impact on the company's bottom line. And as plaintiff attorneys use sympathetic plaintiffs, media bias, and poor juror perception of the drug and device industries to their advantage in high-risk and costly products liability trials, there is simply no room for error in the courtroom.

The time is now for you to benchmark your advocacy strategy and tactics at the ultimate trial skills presentation for pharmaceutical and medical device manufacturers and their counsel.

From soup to nuts, top defense litigators who are in the trenches making news and setting precedents will demonstrate :

  • jury selection;
  • opening and closing statements;
  • cross-examination of the plaintiff, treating physician, and the plaintiff 's epidemiologist, pharmacologist, and regulatory/FDA expert; and
  • direct examination of company witnesses and the defense epidemiologist, pharmacologist, and regulatory/FDA expert

Contents & Contributors

CONDUCTING VOIR DIRE AND SELECTING THE RIGHT JURY
Jan E. Dodd, Kaye Scholer LLP (Los Angeles, CA)

CRAFTING A COMPELLING OPENING STATEMENT - THE PRELIMINARY CASE FOR THE DRUG OR DEVICE
Laura Lewis Owens, Alston & Bird LLP (Atlanta, GA)

CROSS-EXAMINATION OF THE PLAINTIFF
John Joseph Tanner, Baker & Daniels LLP (Indianapolis, IN)

CROSS-EXAMINATION OF THE PRESCRIBING/TREATING PHYSICIAN
Gary J. Spahn, Troutman Sanders LLP (Richmond, VA)

CROSS-EXAMINATION OF THE PLAINTIFF'S EPIDEMIOLOGIST
Joseph J. Leghorn, Nixon Peabody LLP (Boston, MA)

CROSS-EXAMINATION OF THE PLAINTIFF'S REGULATORY/FDA EXPERT
Phoebe A. Wilkinson, Chadbourne & Parke LLP (New York, NY)

CROSS-EXAMINATION OF THE PLAINTIFF'S PHARMACOLOGIST
Lee Davis Thames, Butler, Snow, O'Mara, Stevens & Cannada, PLLC (Jackson, MS)

DIRECT EXAMINATION OF THE COMPANY WITNESS
Steven M. Kohn, Reed Smith LLP (Oakland, CA)

DIRECT EXAMINATION OF IN-HOUSE SCIENTIST
Kenneth J. King, Pepper Hamilton LLP (New York, NY)

TIPS FOR THE EXAMINATION OF AN IN-HOUSE SALES AND MARKETING WITNESS
Sara J. Gourley, Sidley Austin LLP (Chicago, IL)

CROSS-EXAMINATION OF THE COMPANY REGULATORY WITNESS
Andrea Roberts, Baker & Daniels LLP (Indianapolis, IN)

WHAT CAN YOU DO WITH AN EPIDEMIOLOGIST?
Joseph K. Hetrick, Dechert LLP (Philadelphia, PA)

DIRECT EXAMINATION OF THE DEFENSE REGULATORY/FDA EXPERT
David Schrader, Morgan, Lewis & Bockius LLP (Los Angeles, CA)

DIRECT EXAM: COMPANY PHARMACOLOGIST
Joseph P. McMenamin, McGuireWoods LLP (Richmond, VA)

PERSUADING RELUCTANT JURORS THROUGH A WELL-CRAFTED CLOSING ARGUMENT
John E. Hall, Covington & Burling LLP (Washington, DC)



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0